New England Partners is out of business. It is a private equity and venture capital firm that invests in early, mid, and late stage
New England Partners is out of business. It is a private equity and venture capital firm that invests in early, mid, and late stage companies. The firm also participates in all stages of equity financing needs, from a first institutional round of equity to a mezzanine round before an IPO. It makes equity investments in technology, healthcare, and consumer product sectors. Within the technology sector, the firm concentrates on Internet, software, hardware, and communications industries. In healthcare, it targets biopharmaceutical, biotechnology, medical device, and e-health companies. For consumer products, the firm seeks to invest in companies that can offer distinctive products in a mass-market retail channel setting. It typically, invests between $5,00,000 and $10 million. However, the firm also syndicates with other venture capital or strategic investors for companies with greater financial needs. It prefers to acquire a board seat in its portfolio companies. The firm exits its portfolio companies by way of a sale to a financial investor or strategic buyer, IPO, or through recapitalization. It is a licensed Small Business Investment Company. New England Partners was founded in 1992 and is headquartered in Quincy, Massachusetts with additional office in Boston, Massachusetts
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 29, 2006
Magellan Diagnostics
|
Private Equity(PE) | $50M | Health Care | — |
Sep 8, 2005
A&G Pharmaceutical
|
Series A | $2M | Biotechnology | Yes |
Jul 16, 2004
ChipWrights
|
Series D | $13.60M | Manufacturing | — |
May 18, 2004
Panacos Pharmaceuticals
|
Post-IPO Equity | $18.30M | Biotechnology | — |
Oct 10, 2003
OmniSonics Medical Technologies
|
Series C | $43M | Health Care | — |
New England Partners has had 8 exits. New England Partners most notable exits include Magellan Diagnostics , Medivance
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Mar 29, 2016 | Magellan Diagnostics | M&A | Health Care | Detail |
Nov 10, 2011 | Medivance | M&A | Biotechnology | Detail |
Feb 7, 2011 | OmniSonics Medical Technologies | M&A | Health Care | Detail |
Oct 17, 2005 | Goldpocket Interactive | M&A | Enterprise Software | Detail |
Jun 10, 2005 | Panacos Pharmaceuticals | IPO | Biotechnology | Detail |